Evidence map›Paper›PMID 32313671›Full record

ArticleObesity science & practice2020

Utility of BMIQ, a novel web-based weight management programme, at an academic weight management centre.

Sarah R Barenbaum, Sherin E Mathews, Katherine H Saunders, Guadalupe Minero, Elizabeth Mauer, Louis J Aronne, Alpana P Shukla

Abstract read
In one paragraph

Article in Obesity science & practice, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sarah R BarenbaumComprehensive Weight Control Center, Division of Endocrinology Diabetes, and Metabolism, Weill Cornell Medicine New York New York.
Sherin E MathewsComprehensive Weight Control Center, Division of Endocrinology Diabetes, and Metabolism, Weill Cornell Medicine New York New York.
Katherine H SaundersComprehensive Weight Control Center, Division of Endocrinology Diabetes, and Metabolism, Weill Cornell Medicine New York New York.
Guadalupe MineroBMIQ Greenwich Connecticut.
Elizabeth MauerDepartment of Healthcare Policy and Research Weill Cornell Medicine New York New York.
Louis J AronneComprehensive Weight Control Center, Division of Endocrinology Diabetes, and Metabolism, Weill Cornell Medicine New York New York.
Alpana P ShuklaComprehensive Weight Control Center, Division of Endocrinology Diabetes, and Metabolism, Weill Cornell Medicine New York New York.ORCID https://orcid.org/0000-0002-4763-2350

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBMIQ is a customizable online platform used to deliver evidence-based behavioural management that complements office visits with healthcare providers. BMIQ offers educational materials, meal plans and tracking tools for patients, and remote monitoring and guidance for physicians. In this retrospective chart review, the implementation and utility of BMIQ was assessed in patients treated at the Comprehensive Weight Control Center (CWCC) at Weill Cornell Medicine.

methodsThe study included all new patients seen at the CWCC between 9/1/2016 and 6/1/2017 who enrolled in BMIQ. Use of BMIQ was assessed by the number of enrolled patients who activated their account and viewed BMIQ sessions. Demographics, comorbidities, medications, and weight change during 6-month follow-up were obtained from the electronic medical records.

resultsOf the 495 new patients enrolled in BMIQ, 217 met the inclusion criteria of 6-month follow-up. The mean age was 50.2 (±13.1) and 72% (n = 157) were female. Sixty-four percent (n = 138) activated their BMIQ account and viewed greater than or equal to 1 BMIQ session. The average number of physician and registered dietitian visits were 3.5 (±1.1) and 1.9 (±1.6), respectively. The average number of weight loss medications was 1.6 with metformin being the most commonly prescribed (76%). Mean weight loss at 6 months was 7.0 ± 5.9%; 59% achieved greater than or equal to 5% weight loss and 28% achieved greater than or equal to 10% weight loss. The total number of physician visits and weight-loss pharmacotherapies used were significant predictors of patients achieving greater than or equal to 5% weight loss. Regular BMIQ usage was an independent predictor of patients achieving both greater than or equal to 5% and greater than or equal to 10% weight loss at 6 months.

conclusionClinically significant weight loss was achieved in the majority of patients with limited in-clinic physician and registered dietitian follow-up in combination with BMIQ. This retrospective study demonstrates the utility of online behavioural therapy as part of a medical weight management intervention.

Indexed as

anti‐obesity pharmacotherapyBMIQonline behavioural programmeweight loss

Identifiers

PMID32313671
PMCPMC7156832

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.